Faegre Drinker Biddle & Reath LLP, a Delaware limited liability partnership | This website contains attorney advertising.
March 04, 2019

Lower Drug Prices Aren't Worth Higher Health Risks

Libby Baney co-authored an article with Thomas E. Menighan, BSPharm, MBA, FAPhA for Drug Topics on the importance of patient safety instead of more affordable medication. 

"While we share the goal of increasing patient access to safe, affordable medicine, the potential cost-saving benefits of importation policies must be sufficiently weighed to account for the considerable risks to patients."Baney and Menighan, drug topics
Full Article

Related Legal Services